Press Releases - 2023-02-22

Date	Title	Company
22-Feb-2023	Essex and Henlius signed amendment agreement for Global Co-Development and Exclusive License Agreement for treatment of age-related macular degeneration	Essex Bio-Technology Limited
22-Feb-2023	Precocious Puberty Treatment Market to reach US$ 3,650.66 million by 2033	MARKITWIRED
22-Feb-2023	Large Granular Lymphocytic Leukemia Therapeutics Market to reach US$ 12,700 million by 2033	MARKITWIRED
22-Feb-2023	Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European biotech investors	ABIVAX
22-Feb-2023	Glucose Monitoring Devices Market is expected to reach US$ 118.1 Billion by 2033	MARKITWIRED
22-Feb-2023	Migraine Treatment Market is expected to grow with a 4% CAGR during 2023 to 2033	MARKITWIRED
22-Feb-2023	Nipah Virus Infection Testing Market is expected to grow with a 5.2% CAGR from 2023 to 2033	MARKITWIRED
22-Feb-2023	Intraocular Lymphoma Treatments Market is projected to reach US$ 2.3 Billion by 2033	MARKITWIRED
22-Feb-2023	Pharma Targeting Celebrates 10 years of Connecting People Intelligently	Pharma Targeting
22-Feb-2023	AELIX Therapeutics presents positive results from randomized placebo-controlled phase IIa therapeutic HIV vaccine and immune modulator combination clinical trial	AELIX Therapeutics
22-Feb-2023	MODERNA AND LIFE EDIT THERAPEUTICS ENTER STRATEGIC COLLABORATION TO ACCELERATE THE DEVELOPMENT OF NOVEL IN VIVO GENE EDITING THERAPIES	MODERNA
22-Feb-2023	CANCER PATIENTS DEALT CRUEL BLOW AFTER LIFE-EXTENDING TREATMENT KNOCKED BACK BY NICE	Myeloma UK
22-Feb-2023	PHARMANOVIA ENTERS IN-LICENSING AGREEMENT WITH AXSOME THERAPEUTICS TO MARKET AND FURTHER DEVELOP SUNOSI® (SOLRIAMFETOL), A FIRST-IN-CLASS TREATMENT FOR EXCESSIVE DAYTIME SLEEPINESS (EDS) IN PEOPLE WITH NARCOLEPSY AND OBSTRUCTIVE SLEEP APNOEA	PHARMANOVIA
22-Feb-2023	NICE Publishes Reimbursement Recommendation for Translarna™	PTC Therapeutics, Ltd.
22-Feb-2023	Ferrer acquires worldwide rights to ASN90, an O-GlcNAcase inhibitor from Asceneuron, exclusively to treat Progressive Supranuclear Palsy (PSP)	Ferrer
22-Feb-2023	ViiV Healthcare receives EU Marketing Authorisation for Triumeq PD, the first dispersible single tablet regimen containing dolutegravir, a once-daily treatment for children living with HIV in Europe	ViiV Healthcare
22-Feb-2023	Mettler-Toledo to Host a Live Webinar on Glass in Glass X-ray Inspection	Mettler-Toledo
22-Feb-2023	eXmoor pharma and vaccine developer Imophoron sign process development partnership	eXmoor pharma
22-Feb-2023	UK HEALTH-TECH PLATFORM FLORENCE ANNOUNCES FURTHER GROWTH WITH EXPANSION INTO CANADA	Florence
22-Feb-2023	Prof. Molly Stevens receives the Novo Nordisk Prize – Understanding how materials and biology interact has revolutionised healthcare technologies	Novo Nordisk Foundation